Clinical Trial: A Phase 2 Study of YA-101 in Patients with Multiple System Atrophy

U.S., Feb. 27 -- ClinicalTrials.gov registry received information related to the study (NCT06848231) titled 'A Phase 2 Study of YA-101 in Patients with Multiple System Atrophy' on Feb. 17.

Brief Summary: This is a Phase 2, double-blind, placebo-controlled, multi-center, Phase II, dose escalation study to evaluate the safety, tolerability, pharmacokinetics and efficacy of Ya-101 in subjects with multiple system atrophy.

Study Start Date: March 01

Study Type: INTERVENTIONAL

Condition: Multiple System Atrophy

Intervention: DRUG: YA-101

Drug: YA-101

* YA-101 taken BID

DRUG: Placebo

Placebo taken BID

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Yoda Therapeutics Inc.

Published by HT Digital Content Services with permission from ...